Please login to the form below
PharmaLex
This page shows the latest PharmaLex news and features for those working in and with pharma, biotech and healthcare.
PharmaLex announces joint venture with Vintura
We are very excited to be joining forces with the PharmaLex Group," said Gérard Klop, partner at Vintura. ... In addition, the international footprint of PharmaLex supports our international growth objectives," he added.
Latest news
-
PharmaLex expands its footprint to Italy
The consultancy opens new office in Milan. Development consulting and affairs group PharmaLex has expanded its operations to Italy, opening a new office in Milan. ... Acting as a base for PharmaLex Italy, the new location will be headed by regulatory
-
PharmaLex strikes up AI collaboration with Volv
The duo will develop pharmacovigilance products and services. Development consulting and affairs group PharmaLex has teamed up with privately held Volv Global to bolster its pharmacovigilance business. ... Dr Thomas Dobmeyer, chief executive officer of
-
PharmaLex expands with new Paris office
Dr Thomas Dobmeyer, co-chief executive officer of PharmaLex, said: “For the pharmaceutical industry, France plays a significant role on an international level. ... Guillaume commented: “Together with Patrick Larcier, I am excited to have planted the
-
Alapis acquires Pharmalex for USD 19.5m
Greece-headquartered Pharmalex is not operational at the moment but previously ran production and distribution activities in the region. ... The Pharmalex purchase is the latest in a raft of buy ups across central and southern Europe.
More from news
Approximately 4 fully matching, plus 1 partially matching documents found.
Latest Intelligence
-
Brexit Means Brexit
EU27 markets,” says Jonathan Trethowan, VP, Regulatory and Scientific Policy, PharmaLex.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest appointments
-
PharmaLex strengthens international team
Consultancy group appoints Adrian Pencak. PharmaLex Group has appointed new executive vice president, business development and marketing in the form of Adrian Pencak. ... Dr Thomas Dobmeyer, chief executive officer at PharmaLex, said: “Adrian’s
-
PharmaLex appoints Dr Adam King to its regulatory team
PharmaLex has appointed Dr Adam King as its senior director, regulatory affairs and service area, a role that will see him work on regulatory activities related to mergers and acquisitions. ... He said: “I am excited to be part of the PharmaLex team
-
PharmaLex appoints Zabin Younes as associate director
She joins from ERA Consulting. Development consulting and scientific affairs firm PharmaLex Group has expanded its regulatory team with the addition of Zabin Younes. ... Zabin comes to us with a wealth of experience,” said Dr Thomas Dobmeyer, CEO of
-
PharmaLex Group strengthens development consulting team
Friedrichsdorf, Germany-based PharmaLex Group has bolstered its development consulting division with the appointments of Carolyn Belcher and Lutz Wevelsiep. ... Belcher (pictured right) joins PharmaLex as executive vice president of development
More from appointments
Approximately 4 fully matching, plus 0 partially matching documents found.
Latest from PMHub
-
PharmaLex - Confidence beyond Compliance
PharmaLex is one of the largest global specialized providers of Development Consulting, Regulatory Affairs, Quality Management &Compliance and Pharmacovigilance, Epidemiology &Risk Management worldwide. ... PharmaLex - Confidence beyond Compliance.
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- EMA clears BMS’ oral multiple sclerosis drug Zeposia
- GSK plans to produces one billion doses of vaccine adjuvant for COVID-19
- EMA clears BMS’ oral multiple sclerosis drug Zeposia
- Roche/Gilead tag team fights COVID-19 with Actemra/remdesivir
- Merck’s Keytruda hits the mark in triple negative breast cancer
- Finalists 2020 - Communiqué Awards
- ASCO: Momentum gathers behind next wave of CAR-T therapies
- Lilly starts world first trial of an antibody drug for COVID-19
- Pfizer’s Ibrance misses the mark in early breast cancer
- Rise of the patient influencer
- Working together against COVID-19
- Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
PMHub
IGNIFI
We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...
Latest intelligence
- Working together against COVID-19
- Analysing social media conversations to see what HCPs are saying online about the global pandemic...
- Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
- Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
- Are biobetters a market access opportunity?
- Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....
Quick links
Infographics
